Antipsychotic treatment of schizophrenia. We can do better
Authors:
- 1 August 2017
- journal article
- Published by Elsevier in Asian Journal of Psychiatry
- Vol. 28, A1-A2
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Effects of oral versus long-acting antipsychotics on social functioning: A psychiatrists’ survey in IndiaAsian Journal of Psychiatry, 2017
- Clozaphobia: Is avoidance of clozapine in diabetes warranted?Asian Journal of Psychiatry, 2017
- A critical appraisal of long acting injectable antipsychotics: Translating research to clinicsAsian Journal of Psychiatry, 2017
- Treatment retention of risperidone long-acting injection in patients with early-onset schizophrenia in JapanAsian Journal of Psychiatry, 2017
- Prescription practices and attitude of psychiatrists towards clozapine: A survey of psychiatrists from IndiaAsian Journal of Psychiatry, 2015
- Treatment of early episode in patients with schizophrenia: the role of long acting antipsychoticsEuropean Psychiatry, 2014
- Antipsychotic treatment of schizophrenia: An updateAsian Journal of Psychiatry, 2014
- Logic and justification for dimensional assessment of symptoms and related clinical phenomena in psychosis: Relevance to DSM-5Schizophrenia Research, 2013
- Antipsychotics in the Treatment of SchizophreniaThe Journal of Clinical Psychiatry, 2011
- The second-generation ‘atypical’ antipsychotics: similar improved efficacy but different neuroendocrine side effectsPsychoneuroendocrinology, 2003